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Abstract: In oral and oropharyngeal squamous cell carcinoma (OCSCC and OPSCC) exist an association between 
clinical and histopathological parameters with cell proliferation, basal lamina, connective tissue degradation and 
surrounding stroma markers. We evaluated these associations in Chilean patients. A convenience sample of 37 
cases of OCSCC (n=16) and OPSCC (n=21) was analyzed clinically (TNM, clinical stage) and histologically (WHO 
grade of differentiation, pattern of tumor invasion). We assessed the expression of p53, Ki67, HOXA1, HOXB7, 
type IV collagen (ColIV) and carcinoma-associated fibroblast (α-SMA-positive cells). Additionally we conducted a 
univariate/bivariate analysis to assess the relationship of these variables with survival rates. Males were mostly 
affected (56.2% OCSCC, 76.2% OPSCC). Patients were mainly diagnosed at III/IV clinical stages (68.8% OCSCC, 
90.5% OPSCC) with a predominantly infiltrative pattern invasion (62.9% OCSCC, 57.1% OPSCC). Significant associa-
tion between regional lymph nodes (N) and clinical stage with OCSCC-HOXB7 expression (Chi-Square test P < 0.05) 
was observed. In OPSCC a statistically significant association exists between p53, Ki67 with gender (Chi-Square 
test P < 0.05). In OCSCC and OPSCC was statistically significant association between ki67 with HOXA1, HOXB7, and 
between these last two antigens (Pearson’s Correlation test P < 0.05). Furthermore OPSCC-p53 showed significant 
correlation when it was compared with α-SMA (Kendall’s Tau-c test P < 0.05). Only OCSCC-pattern invasion and 
OPSCC-primary tumor (T) pattern resulted associated with survival at the end of the follow up period (Chi-Square 
Likelihood Ratio, P < 0.05). Clinical, histological and immunohistochemical features are similar to seen in other 
countries. Cancer proliferation markers were associated strongly from each other. Our sample highlights prognostic 
value of T and pattern of invasion, but the conclusions may be limited and should be considered with caution (small 
sample). Many cases were diagnosed in the advanced stages of the disease, which suggests that the diagnosis of 
OCSCC and OPSCC is made late.
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p53, ki67, HOX genes, type IV collagen, carcinoma-associated fibroblast
Introduction
Oral cavity squamous cell carcinoma (OCSCC) 
is one of the six most common types of cancer 
in humans, with an annual incidence of 
300,000 cases worldwide [1]. It represents 
95% of all head and neck cancers, and with an 
increasing incidence over the last decade [2]. It 
is often diagnosed in advanced stages and the 
overall 5-year survival is below 50% [2], but 
early diagnosis is associated with high survival 
rates [3]. Tobacco and alcohol are present in 
90% of cases [3], having both a synergetic 
effect [4]. Oropharyngeal squamous cell carci-
noma (OPSCC) comprises tonsil and the base of 
tongue as well as the walls of the pharynx and 
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the soft palate [5], shares the same risk factors 
that OCSCC, showing a subgroup associated to 
high-risk types of human papillomavirus (HPV), 
especially HPV16 [6]. In OCSCC and OPSCC 
exist an association between clinical and histo-
pathological parameters with markers of cell 
proliferation, basal lamina and connective tis-
sue degradation and surrounding stroma cells 
[7]. In order to study these associations, the 
aim of this study was to make a descriptive 
analysis in OCSCC/OPSCC Chilean patients, 
with focus in TNM, WHO grade of differentia-
tion, proliferation, invasion, myofibroblasts and 
HOX genes markers. Additionally we conducted 
a univariate and bivariate analysis to assess 
the relationship between these variables with 
survival rates.
Material and methods
A retrospective analysis was made in files of 
Carlos Van Büren Hospital (Valparaíso, Chile) 
during the period from 2000 to 2010. All the 
specimens were incisional biopsies from pa- 
tients with a diagnosis of OCSCC (n=16) and 
OPSCC (n=21), and new slides stained with 
hematoxylin and eosin were performed for a 
previous examination and histological descrip-
tion. Clinicopathological data, such as sex, site 
of the primary tumour, and clinical staging, 
were collected from patient’s charts. The use of 
the samples and procedures were approved by 
the Hospital Scientific Committee and the 
Bioethics Committee of the University of Talca 
(number 2013-051, http://www.cesarrivera.cl/
research/ethics051.pdf). Immunohistochemi- 
cal techniques were executed in the Pathology 
Department, Faculty of Dentistry, University of 
Campinas, Piracicaba, Brazil, and the Depar- 
tment of Stomatology, University of Talca, Talca, 
Chile. In order to preserve confidentiality, data 
was encrypted.
Histopathological features
After the selection of incisional biopsy speci-
mens from each case, new sections 5 µm thick 
were taken from the fixed paraffin blocks. The 
sections were stained with hematoxylin-eosin 
and were re-evaluated under light microscopy 
by two different observers independently, who 
did not know the clinical data (blind study). 
Table 1. Clinical and pathological character-
istics of patients with OCSCC (n = 16) and 
OPSCC (n = 21)
Features OCSCCn (%)
OPSCC
n (%)
Gender
    Female 7 (43.8) 5 (23.8)
    Male 9 (56.2) 16 (76.2)
TNM
Primary tumor (T)
    T1 3 (18.8) 5 (23.8)
    T2 5 (31.3) 5 (23.8)
    T3 2 (12.5) 5 (23.8)
    T4 6 (37.5) 6 (28.6)
Regional lymph nodes (N)
    0 8 (50) 6 (28.6)
    1 4 (25) 5 (23.8)
    2 3 (18.8) 8 (38.1)
    3 1 (6.2) 2 (9.5)
Metastasis (M)
    M0 16 (100) 21 (100)
Clinical Stage
    I/II 5 (31.2) 2 (9.5)
    III/IV 11 (68.8) 19 (90.5)
Differentiation degree
    Well 4 (25) 1 (4.8)
    Moderate 8 (50) 17 (81)
    Poor 4 (25) 3 (14.3)
Pattern of tumor invasion
    Cohesive 5 (37.1) 9 (42.9)
    Infiltrative 11 (62.9) 12 (57.1)
Survival state
    Alive@ 7 (43.8) 6 (31.6)
    Deceased┼ 9 (56.2) 13 (68.4)*
@Percentage for those who remain alive until the end of 
the follow up period with specified feature. ┼Percentage 
of those who have died with the specified feature. *In 
survival of OPSCC patients 2 cases were excluded from 
the analysis.
Table 2. Survival of patients with oral and oro-
pharyngeal squamous cell carcinoma n (%)
State Years survival
1 3 4
OCSCC
    Alive 15 (93.8) 8 (50) 8 (50)
    Deceased 1 (6.3) 8 (50) 8 (50)
OPSCC
    Alive 14 (73.7) 10 (52.6) 7 (36.8)
    Deceased 5 (26.3) 9 (47.4) 12 (63.2)
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Each specimen was histologically graded accor- 
ding to the International Classification of Tu- 
mors of WHO: well differentiated, moderately 
differentiated and poorly differentiated. The 
pattern of tumor invasion was analyzed accord-
ing to the grading system proposed by Bryne 
[8], classifying it into cohesive (Bryne 1-2) and 
infiltrative (Bryne 3-4). 
Immunohistochemistry
The reactions were conducted in 3 µm sections 
of the original formalin-fixed, paraffin-embed-
ded tissues that were dewaxed with xylene and 
then hydrated in an ethanol series. The sec-
tions were treated with 3% H2O2 followed by 
antigen retrieval in 10 mM citrate buffer (pH 
6.0) in a pressure cooker. After being washed in 
phosphate-buffered saline (pH 7.4), slides were 
incubated overnight with primary antibodies: 
anti-p53 (DO-7, Dako A/S, Denmark: 1/200), 
anti-Ki67 (MIB-1, Dako A/S, Denmark: 1/100), 
anti-HOXA1 (Polyclonal, Abcam, Cambridge, 
MA, USA 1/100) anti-HOXB7 (4C6, Abcam, 
Cambridge, USA: 1/100), anti-ColIV (CIV22; Bio 
SB, Santa Barbara, USA: 1/20), anti-α-SMA 
(1st 4; Dako A/S, Denmark: 1/100) followed by 
the LSAB method (LSAB + kit System-HRP, 
Dako). All slides were subsequently exposed to 
avidin-biotin complex and horseradish peroxi-
dase reagents (LSAB kit; DakoCytomation, Glos- 
trup, Denmark) and diaminobenzidine tetrahy-
drochloride (Sigma, St. Louis, MO) and subse-
quently counterstained with Carazzi hematoxy-
lin. Adequate positive control sections were 
used for each antibody, and the negative con-
trol was obtained by omitting the primary spe-
cific antibody.
Immunohistochemical analysis
For quantitative analysis the stained slides 
were scanned using an Aperio ScanScope CS 
scanner (Aperio Technologies Inc., USA). The 
labeling index for p53, Ki-67, HOXA1 and HOX- 
B7 was measured with the Aperio’s IHC Nuclear 
Image Analysis algorithm (NIA). The NIA was 
split into two categorical groups (high and low), 
where the median was the cutoff point. ColIV 
staining was evaluated by two researchers, 
along the basement membrane of carcinomas 
and classified as continuous (C=a strip remains 
Figure 1. Aperio’s IHC Nuclear Image Analysis. Rows show each antigen evaluated by Aperio. Columns correspond 
to values over and under of median. Sometimes it was necessary to defining the assessment area (in colors) for 
subsequent analysis.
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in the basal membrane), discontinuous (D=a 
fragmented membrane) and absent (A=when 
no staining was observed) [9], and then dichot-
omized (D/A and C). Presence of α-SMA was ra- 
ted as negative + scarce (N/S) or abundant (A).
Statistical analysis
The interobserver concordance was evaluated 
through Lin coefficient for percentages and 
Kappa for categorized variables. The Kolmo- 
gorov-Smirnov test was used to test the hypoth-
esis of normality. The relationship between the 
clinicopathological characteristics and survival 
status at follow-up was assessed using cross 
tables with Chi-Square Like-lihood Ratio (LR), 
Pearson’s Correlation and Kendall’s Tau-c test. 
Survival curves were created using the Kaplan 
Meier method with comparisons through the 
log rank test. In all the procedures a 95% confi-
dence interval (CI) was used.
Figure 2. Expression of basal lamina degradation (OCSCC) and carcinoma-associated fibroblast (OPSCC) markers. 
Table 3. Labeling index for each antigen
OCSCC OPSCC
Antigen NIA mean ± SD NIA Median Mode NIA mean ± SD NIA median Mode
p53 29.1 ± 28 23.5 - 23.5 ± 27.8 6 -
ki67 41.4 ± 8.2 40.5 - 45.2 ± 13.8 47 -
HOXA1 36.2 ± 10.2 30.5 - 39.6 ± 10.8 38 -
HOXB7 41.9 ± 12.1 42 - 44.2 ± 11.5 43 -
ColIV - - D/A (n=16) - - D/A (n=20)
α-SMA - - N/S (n=11) - - N/S (n=14)
SD, standard deviation; D/A, Discontinuous + Absent; N/S, Negative + Scarce.
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Results
Patients-age, sex, clinical stage and survival 
Table 1 summarizes the main clinical and 
pathologic features observed. For all micro-
scopic analysis, interobserver agreement (cat-
egorized variables) ranged from 75% to 97% 
among the examiners. Age of OCSCC patients 
ranged from 41 to 79 years with a median of 
63.9 years for OCSCC patients and 60.4 for 
OPSCC. Males were mostly affected, with 
56.2% in OCSCC and 76.2% in OPSCC. Patients 
were mainly diagnosed at III/IV clinical stages 
(68.8% OCSCC, 90.5% OPSCC) with a predomi-
nantly infiltrative pattern invasion (62.9% in 
OCSCC, 57.1% in OPSCC). Fifteen deaths from 
OPSCC group were registered and 2 not linked 
Table 4. Correlation between antigens expression and clinicopathological variables in oral and oropha-
ryngeal squamous cell carcinomas
OCSCC# OPSCC
Characteristic p53 ki67 HOXA1 HOXB7 α-SMA p53 ki67 HOXA1 HOXB7 COLIV α-SMA
Clinic
Gender 0.614 0.614 0.614 0.949 0.377 0.015* 0.696 0.027* 0.157 0.567 0.469
Primary tumor 1 0.317 1 0.614 0.59 0.835 0.505 0.256 0.123 0.283 0.537
Regional lymph nodes 0.317 0.317 0.003 0.012* 0.59 0.89 0.407 0.163 0.269 0.517 0.306
Clinical stage 1.06 0.59 1.06 0.049* 0.513 0.943 0.943 0.83 0.156 0.740 0.599
Histopathology
Differentiation degree 1 1 1 0.771 0.755 0.283 0.283 0.237 0.283 0.819 0.469
Pattern of tumor invasion 0.59 0.59 0.59 0.838 0.611 0.130 0.256 0.899 0.801 0.375 1
#In OCSCC COLIV antigen was removed; no statistics are computed because COLIV is a constant. Features were correlated with by cross-tabulation 
and the Chi-Square test (only p-value is shown). *p ≤ 0.05.
Table 5. Correlation between antigens immunoexpression in oral and oropharyngeal squamous cell 
carcinomas
OCSCC# OPSCC
Antigens p53 ki67 HOXA1 HOXB7 α-SMA p53 ki67 HOXA1 HOXB7 COLIV α-SMA
p53
    Correlation - -0.151 -0.377 -0.006 0.174 - -0.003 0.009 -0.128 -0.125 0.389
    P-value - 0.577 0.151 0.983 0.427 - 0.990 0.579 0.579 0.508 0.040*
Ki67
    Correlation -0.006 - 0.749 0.801 0.125 -0.003 - 0.609 0.605 -0.204 -0.184
    P-value 0.983 - 0.001 *** 0.57 0.990 - 0.003** 0.019* 0.282 0.331
HOXA1
    Correlation -0.151 0.801 - 0.809 -0.1 0.009 0.009 - 0.815 -0.203 -0.098
    P-value 0.577 *** - *** 0.649 0.579 0.579 - *** 0.282 0.601
HOXB7
    Correlation -0.006 0.801 0.809 - -0.212 -0.128 0.609 0.815 - -0.098 -0.098
    P-value 0.983 *** *** - 0.335 0.579 0.003** *** - 0.601 0.601
ColIV
    Correlation - - - - - -0.125 -0.204 -0.203 -0.093 - 0.158
    P-value - - - - - 0.508 0.282 0.282 0.620 - 0.480
α-SMA
    Correlation 0.174 0.125 -0.1 -0.212 - 0.389 -0.184 -0.021 -0.098 0.158 -
    P-value 0.427 0.57 0.649 0.335 - 0.040* 0.331 0.911 0.601 0.480 -
#In OCSCC COLIV antigen was removed, no statistics are computed because COLIV is a constant. For comparision between nu-
merical variables Pearson’s Correlation was used. In numerical vs categorical variables Kendalls Tau-c was used. For compari-
sion between categorical variables Kendalls Tau-b was used. *P < 0.05, **P < 0.01, ***P < 0.001.
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to cancer (respiratory failure and brain-cranial 
trauma), which were excluded from the analy-
sis. Table 2 shows the survival for 1, 3, and 4 
years after diagnosis.
Table 6. Association between survival status and clinical, pathological and immunohistochemical 
parameters of patients with OCSCC and OPSCC n (%)
State
OCSCC OPSCC
Characteristic Alive
@
7 (43.8)
Deceased#
9 (56.2) LR P value
Alive@
6 (31.6)
Deceased#
13 (68.4)* LR P value
Clinic
Gender 1.189 0.276 2.421 0.120
  Female 2 (28.6) 5 (71.4) 3 (60) 2 (40)
  Male 5 (55.6) 4 (44.4) 3 (21.4) 11 (78.6)
Primary tumor (T) 0.255 0.614 10.239 0.001**
  T1/T2 4 (50) 4 (50) 6 (60) 4 (40)
  T3/T4 3 (37.5) 5 (62.5) 0 9 (100)
Regional lymph nodes (N) 2.348 0.125 5.754 0,16
    N0 5 (62.5) 3 (37.5) 0 6 (100)
    N+ 2 (25) 6 (75) 6 (46.2) 7 (53.8)
Clinical stage 0.779 0.377 1.624 0.202
    I/II 3 (60) 2 (40) 0 2 (100)
    III/IV 4 (36.4) 7 (63.6) 6 (35.3) 11 (64.7)
Histopathology
Differentiation degree 0.84 0.772 0.784 0.376
    Well 2 (50) 2 (50) 0 1 (100)
    Moderate/Poor 5 (41.7) 7 (58.3) 6 (33.3) 12 (66.7)
Pattern of tumor invasion 4.035 0.045* 2.177 0.140
    Cohesive 4 (80) 1 (20) 4 (50) 4 (50)
    Infiltrative 3 (27.3) 8 (72.7) 2 (18.2) 9 (81.8)
Immunohistochemical
p53 2.348 0.125 0.704 0.401
    Low 5 (62.5) 3 (37.5) 4 (40) 6 (60)
    High  2 (25) 6 (75) 2 (22.2) 7 (77.8)
Ki67 0.255 0.614 2.512 0.113
    Low 4 (50) 4 (50) 5 (45.5) 6 (54.5) 
    High 3 (37.5) 5 (62.5) 1 (12.5) 7 (87.5)
HOXA1 2.348 0.125 2.512 0.113
    Low 2 (25) 6 (75) 5 (45.5) 6 (54.5)
    High 5 (62.5) 3 (37.5) 1 (12.5) 7 (87.5)
HOXB7 0.912 0.340 0.704 0.401
    Low 3 (33.3) 6 (66.7) 4 (40) 6 (60)
    High 4 (57.1) 3 (42.9) 2 (22.2) 7 (77.8)
ColIV - -
    Continuous - - 0 1 (100) 0.784 0.376
    Discontinuous/Absent 7 (43.8) 9 (56.3) 6 (33.3) 12 (66.7)
α-SMA 0.42 0.838
    Negative/Scarce 5 (45.5) 5 (54.5) 4 (33.3) 8 (66.7) 0.47 0.829
    Abundant 2 (40) 4 (60) 2 (28.6) 5 (71.4)
@Percentage for those who remain alive until the end of the follow up period with specified feature. #Percentage of those who 
have died with the specified feature. *In survival of OPSCC patients 2 cases were excluded from the analysis. RV Likelihood 
Ratio, as bigger the number is, more powerful is the marker. *P < 0.05, **P < 0.01.
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Biomarkers expression and bivariate correla-
tions 
Figures 1 and 2 illustrate the immunohisto-
chemical stains performed. Antibodies were 
labeled positivity in all samples tested. All anti-
gen data were normally distributed (Kolmogorov-
Smirnov). Table 3 shows the median of the 
labeling index for each antibody. Table 4 shows 
association between studied biomarkers with 
clinical and histopathological parameters of 
OCSCC and OPSCC. Highlight the significant 
association between regional lymph nodes (N) 
and clinical stage with OCSCC-HOXB7 expres-
sion (Chi-Square test P < 0.05). In OPSCC a sta-
tistically significant association exists between 
p53, Ki67 with gender (Chi-Square test P < 
0.05). When the biomarkers correlation were 
evaluated (Table 5) in OCSCC and OPSCC the 
Pearson’s Correlation test established signifi-
cant association between ki67 with HOXA1, 
HOXB7, and between these last two antigens (P 
< 0.05). Additionally, in OPSCC, p53 showed 
significant correlation when it was compared 
with α-SMA (Kendall’s Tau-c test P < 0.05).
Univariate analysis-survival state 
The association between the immunohisto-
chemical expression with survival was per-
formed. In OSCCC patients pattern of tumor 
invasion resulted significantly associated with 
survival at the end of the follow up period (Chi-
Square Likelihood Ratio, P < 0.05), where cases 
with infiltrative pattern corresponded to the 
88.9% of all OCSCC deaths (Table 6). In OPSCC 
patients, primary tumor (T) has a significant 
association with survival (Chi-Square Likelihood 
Ratio, P < 0.01), T3/T4 cases represents the 
69.2% of all OPSCC deaths (Table 4). All the 
immunohistochemical expression showed no 
association with survival.
Kaplan-Meier survival curves
Survival functions are presented in Figure 3. In 
the study of OCSCC invasion pattern, mean sur-
vival for cohesive group was 8.4 ± 1.4 years 
versus infiltrative, which was 5.5 ± 1.4 years, 
no showing significant differences (Log Rank 
test, P=0.12). Regarding the OPSCC primary 
tumor, median survival for T1/T2 group was 7.1 
± 1.2 years versus T3/T4, which was 2.1 ± 0.5 
years, showing significant differences between 
the pairs (Log Rank test, P=0.003).
Discussion
OCSCC and OPSCC still represent a global 
health problem due of its impact and unpredict-
able behavior. They are tumors that occurs 
mainly in elderly people [3], however it has 
been reported an increase in the incidence of 
OPSCC associated to HPV infection in young 
patients [10]. In our sample, the mean age was 
the seventh decade for both OCSCC and 
OPSCC. No statistical association between the 
ages at diagnosis and survival was previously 
reported [3]. In our research, OCSCC and 
OPSCC affected mostly male, which is similar to 
Figure 3. Kaplan-Meier curves for OCSCC-pattern of tumor invasion and OPSCC-primary tumor. Log Rank test shows 
significant differences between pairs, only in OPSCC.
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previous reports for OCSCC [3, 11] and OPSCC 
[12, 13]. Considering both groups (OCSCC/
OPSCC), the mortality rate grouped by gender 
shows an increment in the women when com-
pared with previously Chilean reports [14]. 
The correlation between HPV, and OPSCC was 
recognized by the International Agency for 
Research against Cancer (IARC) [5]. Further- 
more, HPV-positive and HPV-negative OPSCC 
were suggested to likely be different entities 
[10]. We were not able to determine the pres-
ence of HPV in the sample, which is a limitation. 
Future research should consider this back-
ground, because the cases being HPV16-
positive was shown to have a better clinical 
outcome compared to HPV-negative OPSCC [5].
The management of patients it is determined 
by health status, clinical staging system tumor-
lymph node-metastasis (TNM classification) 
supplemented with additional pathological 
information [15]. In accordance with our find-
ings, T was significantly associated with OPSCC 
survival status. From patients who died, 100% 
had tumors classified as T3/T4, also showing 
significant difference between T1/T2 versus 
T3/T4 group in survival curve. Therefore, a 
more severe classification for T in our sample is 
associated with poor survival. We were unable 
to find articles that inform T as a prognostic fac-
tor in OPSCC. In a previous research [16], from 
tumors of the oral cavity and oropharynx, it was 
demonstrated that the mean tumor thickness 
of patients who died with OCSCC was two times 
higher from those who died without this 
cancer.
Most patients of our sample (68.8% OCSCC, 
90.5% OPSCC) were diagnosed in advanced 
clinical stages (stages III/IV), information con-
sistent with the literature. Chilean National 
Institute of Cancer statistics shows similar 
data, as 78% of their OCSCC patients were 
classified as stages III and IV [17]. A previous 
research evaluated survival and patterns of 
recurrence in 200 oral/oropharyngeal mucosa 
cancers and shows that 72% of patients were 
diagnosed in advanced clinical stages III/IV 
[11].
The World Health Organization (WHO) recom-
mends that the classification based on the 
degree of differentiation should be comple-
mented by the evaluation of pattern of tumor 
invasion (PTI) [18]. In the clinical setting, the 
PTI is considered the most significant feature in 
terms of predictive values [3, 18]. PTI reflects 
malignant biological mechanisms such as the 
loss of contact inhibition and tumor cell motili-
ty. In this research, the PTI has also demon-
strated an association with survival rate in 
OCSCC cases, and 88.9% of patients who died 
at the end of the follow-up showed an infiltrat-
ing pattern invasion. A recent study [19] report-
ed that the PTI of OCSCC in clinical stage I and 
II is predictive for local and regional recurrence 
and disease-specific survival rate. Patients 
who had a pattern with tumoral satellites of ≥ 1 
mm from the main tumor, showed a 42% prob-
ability of recurrence and 21% for death. Another 
study [20] stated that graduation for PTI was an 
independent prognostic factor in OCSCC cases 
and was significantly associated with distant 
metastasis and local recurrence; however there 
was no statistical correlation between PTI and 
other factors such as gender, age, tumor size, 
location and commitment of lymph nodes, clini-
cal stage or degree of tumor differentiation, 
however a higher ranking for the PTI was ana-
lyzed and associated with poor survival rates 
and high probability of recurrence. The signifi-
cant association between the PTI and OCSCC 
survival state in this study further supports this 
fact; however in the survival curves (Kaplan 
Meier), there was not statistically significant dif-
ference between the cohesive versus infiltrat-
ing type. The PTI did not decrease the OCSCC 
survival rates, probably because a larger sam-
ple size will be required for this parameter 
shows its influence.
In OCSCC and OPSCC different stromal cells 
and tumor cells activities were observed. An 
association between cell proliferation markers 
in the basal lamina and connective tissue has 
been identified, where hyperproliferative can-
cer cells may induce ColIV degradation and 
facilitate tumor invasion, also stimulating an 
increase of cancer-associated fibroblasts [7]. 
Looking for immunohistochemical markers, 
which represent molecular events in the pro-
cess of malignant transformation, proliferative 
markers (p53, Ki67, and HOXb7 HOXA1), basal 
membrane markers (COlIV) and tumor stroma 
myofibroblast markers (α-SMA) were studied. 
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Interestingly, interaction among p53, HOXA1, 
and gender was founded in our OPSCC patients, 
which may possibly be explained because head 
and neck cancer is traditionally a disease of 
elderly men with a history of chronic exposure 
to the carcinogenic effects of tobacco and alco-
hol [21].
In our study, the homeobox gene HOXB7 was 
significantly associated with regional lymph 
nodes commitment and clinical stage in 
OCSCC. Previous data suggest that HOXB7 may 
contribute to oral carcinogenesis by increasing 
tumor cell proliferation associated with TNM 
[22]. In OCSCC patients, a strongly positive lin-
ear correlation between Ki67, HOXA1 and 
HOXB7 was observed. Furthermore, in OPSCC 
group Ki67 showed a weak direct correlation 
versus HOXA1 and HOXB7 (these last two fac-
tors presents a strong positive correlation 
again). This evidence is consistent with recent 
findings, reporting that HOXA1 promotes cellu-
lar proliferation in vitro [23] and HOXB7 induces 
the accelerating G1/S transition, promote cell 
growth and proliferation [24].
The failure of applied immunohistochemistry in 
the analysis of molecular markers for predict-
ing prognosis was unexpected. Selection of bio-
markers in our research relied on molecules 
that previously demonstrated a potential prog-
nostic role, and these showed no association 
with survival, which could be due to character-
istics of our sample and storage of biological 
material in the hospital environment and its 
characteristics, that could affect antigen 
retrieval. One of the further difficulties of our 
design was to obtain a larger sample because 
there were missing data in clinical records, 
which not allow increasing the number of 
individuals.
Our results suggest that our patients, clinical, 
histological and immunohistochemical features 
are similar to seen in other countries. Many 
were diagnosed in the advanced stages of the 
disease, which suggests that the diagnosis of 
OCSCC and OPSCC is made late. The parame-
ters associated with the survival state at the 
end of follow up were the OCSCC pattern of 
invasion and OPSCC maximum surface diame-
ter of the primary tumor. Despite the fact that 
our patient material is small, we think it is 
important to explore the survival analysis, 
although the conclusions may be limited and 
should be considered with caution. The large 
battery of markers studied will be allowed to 
compare this data with future new lines of 
investigation.
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